DIR Return Create A Forum - Home
       ---------------------------------------------------------
       Data Report
  HTML https://datareport.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: Covid Treatments
       *****************************************************
       #Post#: 117--------------------------------------------------
       Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in med
       Rxiv Pre-print.
       By: Data Report Date: November 16, 2022, 9:32 pm
       ---------------------------------------------------------
       Bioxytran Releases Positive Top-line Results from Phase 2 Trial
       of Galectin Antagonist on COVID-19 Patients in medRxiv
       Pre-print.
  HTML https://finance.yahoo.com/news/bioxytran-releases-positive-top-line-120000424.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAALYjVS13At1aFyi2T5pMKB9fQDH7Ag3h5oLZJLuOgqSlAvxGaRTf74vuNi8bNc1OhxZWrDZnV6FIxx7b3OweisYbZsrA-bpwsiZwuP0JhkCfhjfsClc3__Wk9lTzROMALkuSNB_7hDMlYrPef10pdPocEPHPiPRK0YHD5zQaf-YM
       *****************************************************